St. Jude Medical Announces Intent to Acquire Spinal Modulation, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
St. Jude Medical (STJ) to Acquire Spinal Modulation in $175M + Milestones Deal
April 20, 2015 9:13 AM EDTSt. Jude Medical (NYSE: STJ) announced it has exercised the companys exclusive option to acquire Spinal Modulation, Inc., developer of the Axium Neurostimulator System. Following the completion of this acquisition, St. Jude Medical will become the only medical device manufacturer to offer radiofrequency ablation (RFA), spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation therapy solutions for the treatment of chronic pain.
Once complete, the acquisition of Spinal Modulation, Inc. will further support St. Jude Medicals mission to help physicians tailor treatment to a patients chronic pain condition to achieve superior... More
